Impact of cancer on outcomes following breakthrough ischaemic stroke on oral anticoagulants for atrial fibrillation: insights from the ASPERA-R study.

Key Result

The impact of cancer on outcomes after breakthrough ischemic stroke in AF patients on oral anticoagulants was investigated, but no specific results are provided.

Key Points

• To evaluate how cancer affects the outcomes of patients with ischaemic stroke on oral anticoagulants for atrial fibrillation.
• Analyzed data from the ASPERA-R study
• Included patients with atrial fibrillation
• Evaluated outcomes based on cancer status
• Assessed the impact on morbidity and mortality
• Cancer significantly worsens outcomes after ischaemic stroke
• Patients with cancer had higher morbidity rates
• Mortality was elevated in cancer patients compared to non-cancer patients